Everett Harris & CO Biogen Inc. Transaction History

Everett Harris & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$190.52 - $236.72 $166,323 - $206,656	873 New	873 $202,000
Q3 2022 Oct 21, 2022	BUY	$194.69 - $268.46 $168,017 - $231,680	863 New	863 $230,000
Q1 2022 Apr 22, 2022	SELL	$193.77 - $244.14 $167,223 - $210,692	-863 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$258.66 - $342.55 $223,223 - $295,620	863 New	863 $231,000

1,016

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

Stay updated on Everett Harris & CO with notifications on news.